Incyte Corp at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good morning, and Happy New Year, everyone. Welcome to the 40th Annual and Second, and hopefully the last time, Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce Herve Hoppenot, the Chairman and CEO of Incyte, our first company to present here today. Please note that following Herve's presentation, we will have a Q&A session right here in the same Zoom room. (Operator Instructions)
And with that, let me turn things over to Herve to get us started. So, Herve, thank you for being here.
Thank you, Cory. It's good to be first and it's a pleasure to speak about Incyte this morning. So I will call the slide numbers as I go through the presentation. So on Slide 2, I must state that safe harbor rules govern my remarks. Any forward-looking statement that I make, can I ask that you please review
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |